Mark Clemons

24PUBLICATIONS
31CO-AUTHORS
Molecular targetsPredictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 07, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker

|Jan 21, 2022
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers.

Mashari Alzahrani, Carol Stober, Michelle Liu

|Jun 27, 2021
Clinical utility of a prediction tool to differentiate between breast cancer patients at high or low risk of chemotherapy-induced nausea and vomiting.

Mashari Jemaan Alzahrani, George Dranitsaris, Marta Sienkiewicz

|Mar 23, 2021
Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey.

Sharon McGee, Mashari Alzahrani, Lisa Vandermeer

|Mar 20, 2021
A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients.

Mark Clemons, Demetrios Simos, Marta Sienkiewicz

|Nov 06, 2020
A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management.

Hely Shah, Julian Surujballi, Arif Ali Awan

Pageof 4

Frequent Collaborators

1 joint publications

David J Stewart

1 joint publications

Hagop M Kantarjian

1 joint publications

Brian Hutton

1 joint publications

Mona Hersi